BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24805800)

  • 1. Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes.
    Jarab AS; Almrayat R; Alqudah S; Thehairat E; Mukattash TL; Khdour M; Pinto S
    Int J Clin Pharm; 2014 Aug; 36(4):725-33. PubMed ID: 24805800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication Non-adherence in Patients with Osteoporosis: Implications for Clinical Pharmacists and Osteoporosis Care Providers.
    Jarab AS; Mukattash TL; Hilan H
    Curr Clin Pharmacol; 2020; 15(3):243-250. PubMed ID: 31951176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria.
    Yusuff KB; Obe O; Joseph BY
    Pharm World Sci; 2008 Dec; 30(6):876-83. PubMed ID: 18784982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring variables associated with medication non-adherence in patients with COPD.
    Jarab AS; Mukattash TL
    Int J Clin Pharm; 2019 Oct; 41(5):1202-1209. PubMed ID: 31468254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated with Poor Hemoglobin A1c Control in Patients with Type 2 Diabetes.
    Alqudah S; Jarab AS; Alefishat EA; Mayyas F; Khdour M; Pinto S
    Curr Diabetes Rev; 2019; 15(2):164-170. PubMed ID: 29745337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between health beliefs and medication adherence among patients with type 2 diabetes.
    Alatawi YM; Kavookjian J; Ekong G; Alrayees MM
    Res Social Adm Pharm; 2016; 12(6):914-925. PubMed ID: 26706405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of patients' disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine.
    Sweileh WM; Zyoud SH; Abu Nab'a RJ; Deleq MI; Enaia MI; Nassar SM; Al-Jabi SW
    BMC Public Health; 2014 Jan; 14():94. PubMed ID: 24479638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: Randomized controlled trial.
    Wishah RA; Al-Khawaldeh OA; Albsoul AM
    Diabetes Metab Syndr; 2015; 9(4):271-6. PubMed ID: 25301007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-line pharmacotherapy for incident type 2 diabetes: Prescription patterns, adherence and associated costs.
    Campbell DJT; Campbell DB; Ogundeji Y; Au F; Beall R; Ronksley PE; Quinn AE; Manns BJ; Hemmelgarn BR; Tonelli M; Spackman E
    Diabet Med; 2021 Sep; 38(9):e14622. PubMed ID: 34133781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
    Hertz RP; Unger AN; Lustik MB
    Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Diabetes-related Knowledge and Medication Adherence: Results From Cross-sectional Analysis.
    Nazir SU; Hassali MA; Saleem F; Bashir S; Aljadhey H
    Altern Ther Health Med; 2016 Nov; 22(6):8-13. PubMed ID: 27866175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes.
    Florez H; Luo J; Castillo-Florez S; Mitsi G; Hanna J; Tamariz L; Palacio A; Nagendran S; Hagan M
    Postgrad Med; 2010 Mar; 122(2):112-20. PubMed ID: 20203462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication Adherence Affects Risk of New Diabetes Complications: A Cohort Study.
    Simpson SH; Lin M; Eurich DT
    Ann Pharmacother; 2016 Sep; 50(9):741-6. PubMed ID: 27307411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension.
    An J; Nichol MB
    Med Care; 2013 Oct; 51(10):879-87. PubMed ID: 23929398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' perspective of disease and medication adherence for type 2 diabetes in an urban area in Bangladesh: a qualitative study.
    Islam SM; Biswas T; Bhuiyan FA; Mustafa K; Islam A
    BMC Res Notes; 2017 Mar; 10(1):131. PubMed ID: 28327202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.
    Mary A; Hartemann A; Liabeuf S; Aubert CE; Kemel S; Salem JE; Cluzel P; Lenglet A; Massy ZA; Lalau JD; Mentaverri R; Bourron O; Kamel S
    Cardiovasc Diabetol; 2017 Feb; 16(1):24. PubMed ID: 28202017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study.
    Rwegerera GM
    Pan Afr Med J; 2014; 17():252. PubMed ID: 25309652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic health literacy and its association with glycemic control among adult patients with type 2 diabetes mellitus attending the outpatient clinic of a university hospital in Ethiopia.
    Tefera YG; Gebresillassie BM; Emiru YK; Yilma R; Hafiz F; Akalu H; Ayele AA
    PLoS One; 2020; 15(4):e0231291. PubMed ID: 32267893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of medication adherence in patients with type 2 diabetes mellitus.
    Curkendall SM; Thomas N; Bell KF; Juneau PL; Weiss AJ
    Curr Med Res Opin; 2013 Oct; 29(10):1275-86. PubMed ID: 23815104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.